CN103232352B - (r)-4-(2-(2-羟基-2-苯乙胺基)乙基)苯胺基甲酸叔丁基酯 - Google Patents
(r)-4-(2-(2-羟基-2-苯乙胺基)乙基)苯胺基甲酸叔丁基酯 Download PDFInfo
- Publication number
- CN103232352B CN103232352B CN201310173875.7A CN201310173875A CN103232352B CN 103232352 B CN103232352 B CN 103232352B CN 201310173875 A CN201310173875 A CN 201310173875A CN 103232352 B CN103232352 B CN 103232352B
- Authority
- CN
- China
- Prior art keywords
- boc
- hydroxyl
- ethyl
- aminophenyl
- anilino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310173875.7A CN103232352B (zh) | 2013-05-11 | 2013-05-11 | (r)-4-(2-(2-羟基-2-苯乙胺基)乙基)苯胺基甲酸叔丁基酯 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310173875.7A CN103232352B (zh) | 2013-05-11 | 2013-05-11 | (r)-4-(2-(2-羟基-2-苯乙胺基)乙基)苯胺基甲酸叔丁基酯 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103232352A CN103232352A (zh) | 2013-08-07 |
CN103232352B true CN103232352B (zh) | 2015-12-23 |
Family
ID=48880436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310173875.7A Active CN103232352B (zh) | 2013-05-11 | 2013-05-11 | (r)-4-(2-(2-羟基-2-苯乙胺基)乙基)苯胺基甲酸叔丁基酯 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103232352B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3177589B1 (en) | 2014-08-06 | 2018-06-20 | Interquim, S.A. | Method for the synthesis of mirabegron and its derivatives |
WO2016024284A2 (en) | 2014-08-07 | 2016-02-18 | Wanbury Ltd. | A process for the preparation of mirabegron and its intermediates |
CN105111165B (zh) * | 2015-09-14 | 2017-10-31 | 保定博洋生物科技有限公司 | 一种米拉贝隆的制备方法 |
KR101868438B1 (ko) | 2017-04-13 | 2018-06-20 | (주) 성운파마코피아 | 아미드 유도체의 제조방법 |
CN111302966A (zh) * | 2020-04-03 | 2020-06-19 | 湖南复瑞生物医药技术有限责任公司 | 一种米拉贝隆中间体的制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6465501B2 (en) * | 2000-07-17 | 2002-10-15 | Wyeth | Azolidines as β3 adrenergic receptor agonists |
US7342117B2 (en) * | 2001-10-30 | 2008-03-11 | Astellas Pharma Inc. | α-form or β-form crystal of acetanilide derivative |
JP3815496B2 (ja) * | 2002-11-07 | 2006-08-30 | アステラス製薬株式会社 | 酢酸アニリド誘導体を有効成分とする過活動膀胱治療剤 |
US8003627B2 (en) * | 2005-10-21 | 2011-08-23 | Universiteit Antwerpen | Urokinase inhibitors |
PE20091825A1 (es) * | 2008-04-04 | 2009-12-04 | Merck & Co Inc | Hidroximetil pirrolidinas como agonistas del receptor adrenergico beta 3 |
JP2011105685A (ja) * | 2009-11-20 | 2011-06-02 | Astellas Pharma Inc | フェネチルアミン化合物の結晶 |
WO2012152807A1 (en) * | 2011-05-09 | 2012-11-15 | Universiteit Antwerpen | Activity-based probes for the urokinase plasminogen activator |
-
2013
- 2013-05-11 CN CN201310173875.7A patent/CN103232352B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN103232352A (zh) | 2013-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103232352B (zh) | (r)-4-(2-(2-羟基-2-苯乙胺基)乙基)苯胺基甲酸叔丁基酯 | |
CN103304511B (zh) | 一种米拉贝隆的合成方法 | |
CN106146517B (zh) | 一种枸橼酸托法替尼的合成方法 | |
EP4163009A1 (en) | Cellulose derivative and metal adsorbent containing said cellulose derivative | |
CN103265457B (zh) | 一种(r)-4-氨基苯乙基-(2-羟基-2-苯乙基)-氨基甲酸叔丁酯的合成方法 | |
CN103113288B (zh) | 一种八氢环戊烯并[c]吡咯羧酸衍生物的合成方法 | |
CN107857702A (zh) | 一种比拉斯汀中间体的制备方法 | |
US10047037B2 (en) | Method for producing 2-amino-substituted benzaldehyde compound | |
CN103467449B (zh) | 一种哌啶衍生物、制备方法及在制备常山酮中的应用 | |
CN110526913A (zh) | 一种抗凝药物阿哌沙班相关物质的制备方法 | |
CN104837817A (zh) | 制备3-氨基-哌啶化合物的新合成路线 | |
Pál et al. | Synthesis and complexation studies of optically active aza-and diazacrown ethers containing a pyrene fluorophore unit | |
CN106316935B (zh) | 一种Abemaciclib中间体的制备方法 | |
CN1865259B (zh) | 一种哌啶衍生物的制备方法 | |
CN102993072A (zh) | 生产蛋氨酸的方法 | |
CN105130870A (zh) | 一种l-焦谷氨酸苄酯的制备方法 | |
CN112745263A (zh) | 一种羟氯喹的制备方法 | |
CN103232368B (zh) | 一种(r)-4-硝基苯乙基-(2-羟基-2-苯乙基)-氨基甲酸叔丁酯的合成方法 | |
US20230072446A1 (en) | Lithium selective organogels | |
CN105777616B (zh) | 色瑞替尼的合成中间体及其制备方法 | |
CN114736173B (zh) | 一种3-(二氟甲基)氧杂环丁烷-3-胺盐酸盐的制备方法 | |
CN101962353B (zh) | 一种(r)或(s)-2-氨甲基四氢吡咯的制备方法 | |
CN113321669B (zh) | 一种磺酰亚胺类金属盐、其制备方法及应用 | |
CN110028469B (zh) | 一种非阿片类镇痛药的关键中间体的制备方法及应用 | |
CN107827916A (zh) | 一种(r)‑(1‑氨基‑3‑甲基)丁基‑1‑硼酸蒎烷二醇酯的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Hu Fan Inventor after: Wang Shenyong Inventor after: Wang Xiaojun Inventor after: Hu Changchun Inventor before: Hu Fan Inventor before: Wang Shenyong Inventor before: Wang Xiaojun Inventor before: Hu Juankai |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200710 Address after: No.6, Gongye Avenue, Conghua Economic Development Zone, Guangzhou City, Guangdong Province, 510900 Patentee after: GUANGDONG XIANQIANG PHARMACEUTICAL Co.,Ltd. Address before: Xinghu street Suzhou Industrial Park in Jiangsu province 215200 BioBAY No. 218 building C9 Room 301 Patentee before: SUZHOU UUGENE BIOPHARMA Co.,Ltd. |
|
TR01 | Transfer of patent right |